Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study
Daniel T Barratt, Benedikte Bandak, Pål Klepstad, Ola Dale, Stein Kaasa, Lona Louring Christrup, Jonathan Tuke, Andrew A Somogyi
33Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study'. Together they form a unique fingerprint.